← CASTLE BIOSCIENCES INC CSTL
Market Price
$29.63
Market Cap
$926.58M
P/E Ratio
N/A
Revenue (FY 2025)
↑3.7% YoY
$344.23M
3-Yr CAGR: 35.9%
Net Income
↓-232.4% YoY
-$24.16M
Net Margin: -7.0%
Free Cash Flow
↓-22.5% YoY
$28.33M
FCF Yield: 3.06%
EPS (Diluted)
↓-233.9% YoY
$-0.83
Basic: $-0.83
Return on Equity
Efficiency
-5.1%
ROA: -303.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CSTL)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | $22.8M | — | $17.5M | $-6.4M | — | $-5.33 | — | $-12.3M | $-12.6M | — |
| FY 2019 | $51.9M | +127.6% | $44.6M | $5.3M | +182.9% | $-0.21 | +96.1% | $7.0M | $6.1M | +148.3% |
| FY 2020 | $62.6M | +20.8% | $53.0M | $-10.3M | -294.9% | $-0.54 | -157.1% | $9.9M | $5.1M | -15.9% |
| FY 2021 | $94.1M | +50.2% | $78.3M | $-31.3M | -204.3% | $-1.24 | -129.6% | $-19.0M | $-22.5M | -539.3% |
| FY 2022 | $137.0M | +45.7% | $105.0M | $-67.1M | -114.6% | $-2.58 | -108.1% | $-41.7M | $-47.3M | -110.5% |
| FY 2023 | $219.8M | +60.4% | $174.8M | $-57.5M | +14.4% | $-2.14 | +17.1% | $-5.6M | $-19.2M | +59.3% |
| FY 2024 | $332.1M | +51.1% | $271.9M | $18.2M | +131.7% | $0.62 | +129.0% | $64.9M | $36.5M | +289.8% |
| FY 2025 | $344.2M | +3.7% | $273.2M | $-24.2M | -232.4% | $-0.83 | -233.9% | $64.3M | $28.3M | -22.5% |
Valuation
Market Price
$29.63
Market Cap
$926.58M
Enterprise Value
$819.91M
P/E Ratio
N/A
P/B Ratio
1.91
FCF Yield
3.06%
Dividend Yield
0.00%
Shares Outstanding
Profitability & Margins
Gross Margin
79.37%
Operating Margin
-12.44%
Net Margin
-7.02%
Return on Equity (ROE)
-5.13%
Return on Assets (ROA)
-303.65%
Asset Turnover
43.27x
Revenue 3-Yr CAGR
35.94%
Financial Health & Liquidity
Current Ratio
0.12
Cash Ratio
1.70
Debt / Equity
0.021
Debt / Assets
1.264
Cash & Equivalents
$116.73M
Total Debt
$10.06M
Book Value / Share
$15.52
Cash Flow Efficiency
Operating Cash Flow
$64.35M
Capital Expenditures (CapEx)
$36.02M
Free Cash Flow
$28.33M
OCF / Revenue
18.69%
FCF / Revenue
8.23%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.83
EPS (Basic)
$-0.83
Dividends / Share
N/A
Book Value / Share
$15.52
EPS YoY Growth
-233.87%
Balance Sheet (FY 2025)
Total Assets
$7.96M
Total Liabilities
$68.68M
Stockholders' Equity
$470.87M
Current Assets
$7.96M
Current Liabilities
$68.68M